MSB 3.21% $1.13 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-216

  1. 2,891 Posts.
    lightbulb Created with Sketch. 2051
    Here you go @whytee ZERO NADA ZILCH KAPUT mention of the FDA not considering LONG TERM SURVIVAL DATA. You have been pulled up on this a few times now. Let's see whether you are prepared to acknowledge you were wrong- or are you deliberately being misleading.
    @LearningEachDay below is the excerpt from the actual ODAC meeting notes.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.